Cerus Corporation (CERS)
USD 1.21
(-6.2%)
USD 1.21
(-6.2%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 84.35 Million USD | 63.31% |
| 2022 | 51.65 Million USD | 33.03% |
| 2021 | 38.82 Million USD | 28.15% |
| 2020 | 30.29 Million USD | 2.83% |
| 2019 | 29.46 Million USD | 2814.34% |
| 2018 | 1.01 Million USD | -93.73% |
| 2017 | 16.11 Million USD | 605.97% |
| 2016 | -3.18 Million USD | 93.77% |
| 2015 | -51.14 Million USD | -296.2% |
| 2014 | -12.9 Million USD | 50.58% |
| 2013 | -26.11 Million USD | -37.67% |
| 2012 | -18.97 Million USD | -3.78% |
| 2011 | -18.28 Million USD | 24.0% |
| 2010 | -24.05 Million USD | -20.83% |
| 2009 | -19.9 Million USD | -93.22% |
| 2008 | -10.3 Million USD | 47.41% |
| 2007 | -19.59 Million USD | 57.56% |
| 2006 | -46.17 Million USD | -5537.48% |
| 2005 | -819 Thousand USD | -384.62% |
| 2004 | -169 Thousand USD | -100.52% |
| 2003 | 32.68 Million USD | 246.03% |
| 2002 | -22.38 Million USD | 65.25% |
| 2001 | -64.42 Million USD | 10.22% |
| 2000 | -71.75 Million USD | -2010.47% |
| 1999 | -3.4 Million USD | -183.33% |
| 1998 | -1.2 Million USD | 89.57% |
| 1997 | -11.5 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 86.29 Million USD | 7.76% |
| 2024 Q3 | 76.32 Million USD | -11.55% |
| 2024 Q1 | 80.07 Million USD | -5.07% |
| 2023 Q4 | 84.35 Million USD | 8.8% |
| 2023 FY | 84.35 Million USD | 63.31% |
| 2023 Q1 | 62.34 Million USD | 20.69% |
| 2023 Q3 | 77.53 Million USD | 15.07% |
| 2023 Q2 | 67.37 Million USD | 8.08% |
| 2022 Q4 | 51.65 Million USD | -11.82% |
| 2022 FY | 51.65 Million USD | 33.03% |
| 2022 Q2 | 55.65 Million USD | 10.94% |
| 2022 Q1 | 50.16 Million USD | 29.2% |
| 2022 Q3 | 58.57 Million USD | 5.26% |
| 2021 Q2 | 22.81 Million USD | -9.2% |
| 2021 Q3 | 3.89 Million USD | -82.93% |
| 2021 Q4 | 38.82 Million USD | 896.59% |
| 2021 FY | 38.82 Million USD | 28.15% |
| 2021 Q1 | 25.13 Million USD | -17.06% |
| 2020 Q4 | 30.29 Million USD | -12.68% |
| 2020 Q2 | 28.95 Million USD | -4.59% |
| 2020 Q1 | 30.34 Million USD | 3.0% |
| 2020 FY | 30.29 Million USD | 2.83% |
| 2020 Q3 | 34.69 Million USD | 19.83% |
| 2019 Q4 | 29.46 Million USD | -26.32% |
| 2019 FY | 29.46 Million USD | 2814.34% |
| 2019 Q1 | 31.3 Million USD | 2996.14% |
| 2019 Q3 | 39.98 Million USD | -1.78% |
| 2019 Q2 | 40.71 Million USD | 30.07% |
| 2018 Q3 | 7.52 Million USD | -51.54% |
| 2018 Q2 | 15.52 Million USD | 3.95% |
| 2018 Q1 | 14.93 Million USD | -7.3% |
| 2018 FY | 1.01 Million USD | -93.73% |
| 2018 Q4 | 1.01 Million USD | -86.56% |
| 2017 Q1 | 7.22 Million USD | 326.91% |
| 2017 FY | 16.11 Million USD | 605.97% |
| 2017 Q4 | 16.11 Million USD | 25.95% |
| 2017 Q3 | 12.79 Million USD | 554.37% |
| 2017 Q2 | -2.81 Million USD | -138.96% |
| 2016 Q2 | 12.14 Million USD | 1361.58% |
| 2016 FY | -3.18 Million USD | 93.77% |
| 2016 Q3 | 6.47 Million USD | -46.74% |
| 2016 Q4 | -3.18 Million USD | -149.22% |
| 2016 Q1 | -963 Thousand USD | 98.12% |
| 2015 Q1 | -8.05 Million USD | 37.63% |
| 2015 Q4 | -51.14 Million USD | -65.31% |
| 2015 Q3 | -30.93 Million USD | -104.02% |
| 2015 Q2 | -15.16 Million USD | -88.36% |
| 2015 FY | -51.14 Million USD | -296.2% |
| 2014 Q1 | -20.72 Million USD | 20.66% |
| 2014 Q4 | -12.9 Million USD | -3.41% |
| 2014 FY | -12.9 Million USD | 50.58% |
| 2014 Q2 | -18.71 Million USD | 9.7% |
| 2014 Q3 | -12.48 Million USD | 33.3% |
| 2013 Q3 | -20.71 Million USD | 63.03% |
| 2013 Q4 | -26.11 Million USD | -26.08% |
| 2013 FY | -26.11 Million USD | -37.67% |
| 2013 Q1 | -62.2 Million USD | -227.89% |
| 2013 Q2 | -56.04 Million USD | 9.91% |
| 2012 FY | -18.97 Million USD | -3.78% |
| 2012 Q4 | -18.97 Million USD | -2.91% |
| 2012 Q3 | -18.43 Million USD | 4.27% |
| 2012 Q2 | -19.25 Million USD | 20.78% |
| 2012 Q1 | -24.31 Million USD | -32.99% |
| 2011 Q3 | -9.85 Million USD | 28.33% |
| 2011 Q4 | -18.28 Million USD | -85.58% |
| 2011 Q2 | -13.74 Million USD | 28.12% |
| 2011 Q1 | -19.12 Million USD | 20.51% |
| 2011 FY | -18.28 Million USD | 24.0% |
| 2010 FY | -24.05 Million USD | -20.83% |
| 2010 Q3 | -7.01 Million USD | 24.5% |
| 2010 Q4 | -24.05 Million USD | -243.09% |
| 2010 Q2 | -9.28 Million USD | 36.05% |
| 2010 Q1 | -14.52 Million USD | 15.88% |
| 2009 FY | -19.9 Million USD | -93.22% |
| 2009 Q1 | -6.98 Million USD | 32.22% |
| 2009 Q3 | -19.44 Million USD | -149.55% |
| 2009 Q4 | -17.26 Million USD | 11.2% |
| 2009 Q2 | -7.79 Million USD | -11.56% |
| 2008 Q3 | -15.29 Million USD | 31.67% |
| 2008 FY | -10.3 Million USD | 47.41% |
| 2008 Q2 | -22.38 Million USD | -3.08% |
| 2008 Q4 | -10.3 Million USD | 32.65% |
| 2008 Q1 | -21.71 Million USD | -10.85% |
| 2007 FY | -19.59 Million USD | 57.56% |
| 2007 Q3 | -37.94 Million USD | -14.23% |
| 2007 Q4 | -19.59 Million USD | 48.37% |
| 2007 Q2 | -33.22 Million USD | 15.02% |
| 2007 Q1 | -39.09 Million USD | 15.33% |
| 2006 Q1 | -52.56 Million USD | -6318.56% |
| 2006 Q2 | -56.52 Million USD | -7.54% |
| 2006 Q3 | -42.42 Million USD | 24.95% |
| 2006 Q4 | -46.17 Million USD | -8.83% |
| 2006 FY | -46.17 Million USD | -5537.48% |
| 2005 Q4 | -819 Thousand USD | -22.42% |
| 2005 Q3 | -669 Thousand USD | -133.1% |
| 2005 FY | -819 Thousand USD | -384.62% |
| 2005 Q1 | -279 Thousand USD | -65.09% |
| 2005 Q2 | -287 Thousand USD | -2.87% |
| 2004 Q3 | 52.49 Million USD | 3.34% |
| 2004 Q4 | -169 Thousand USD | -100.32% |
| 2004 Q2 | 50.79 Million USD | 297.38% |
| 2004 Q1 | -25.73 Million USD | -178.73% |
| 2004 FY | -169 Thousand USD | -100.52% |
| 2003 FY | 32.68 Million USD | 246.03% |
| 2003 Q3 | 1.56 Million USD | 103.93% |
| 2003 Q4 | 32.68 Million USD | 1986.02% |
| 2003 Q2 | -39.87 Million USD | -925.64% |
| 2003 Q1 | -3.88 Million USD | 82.63% |
| 2002 Q3 | -42.06 Million USD | -59.21% |
| 2002 Q4 | -22.38 Million USD | 46.79% |
| 2002 Q1 | -47.88 Million USD | 25.68% |
| 2002 FY | -22.38 Million USD | 65.25% |
| 2002 Q2 | -26.42 Million USD | 44.81% |
| 2001 Q2 | -138.27 Million USD | -100.08% |
| 2001 Q4 | -64.42 Million USD | 35.07% |
| 2001 FY | -64.42 Million USD | 10.22% |
| 2001 Q3 | -99.21 Million USD | 28.25% |
| 2001 Q1 | -69.1 Million USD | 3.69% |
| 2000 Q4 | -71.75 Million USD | 15.61% |
| 2000 FY | -71.75 Million USD | -2010.47% |
| 2000 Q1 | -38.19 Million USD | -1023.44% |
| 2000 Q2 | -35.38 Million USD | 7.37% |
| 2000 Q3 | -85.03 Million USD | -140.32% |
| 1999 Q2 | -4.5 Million USD | -1000.0% |
| 1999 Q1 | 500 Thousand USD | 141.67% |
| 1999 Q3 | -7.4 Million USD | -64.44% |
| 1999 Q4 | -3.4 Million USD | 54.05% |
| 1999 FY | -3.4 Million USD | -183.33% |
| 1998 Q4 | -1.2 Million USD | -300.0% |
| 1998 FY | -1.2 Million USD | 89.57% |
| 1998 Q1 | -6.6 Million USD | 42.61% |
| 1998 Q3 | -300 Thousand USD | -109.38% |
| 1998 Q2 | 3.2 Million USD | 148.48% |
| 1997 Q4 | -11.5 Million USD | 42.21% |
| 1997 Q1 | -28.8 Million USD | 0.0% |
| 1997 FY | -11.5 Million USD | 0.0% |
| 1997 Q2 | -24 Million USD | 16.67% |
| 1997 Q3 | -19.9 Million USD | 17.08% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 27.08 Million USD | -211.469% |
| BrainsWay Ltd. | -10.32 Million USD | 917.364% |
| Envoy Medical, Inc. | -3.81 Million USD | 2311.641% |
| electroCore, Inc. | -9.95 Million USD | 947.333% |
| Helius Medical Technologies, Inc. | -5.12 Million USD | 1745.893% |
| IceCure Medical Ltd | -9.93 Million USD | 949.124% |
| Inogen, Inc. | -103.56 Million USD | 181.445% |
| OrthoPediatrics Corp. | -9.26 Million USD | 1010.241% |
| Lucid Diagnostics Inc. | -3.64 Million USD | 2416.726% |
| Monogram Orthopaedics, Inc. | -13.09 Million USD | 744.054% |
| MaxCyte, Inc. | -27.76 Million USD | 403.829% |
| NeuroOne Medical Technologies Corporation | -5.13 Million USD | 1741.699% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | 14750.371% |
| Orthofix Medical Inc. | 96.44 Million USD | 12.536% |
| PAVmed Inc | 29.08 Million USD | -190.009% |
| Rapid Micro Biosystems, Inc. | -16.93 Million USD | 597.975% |
| RxSight, Inc. | -6.68 Million USD | 1362.754% |
| Sight Sciences, Inc. | -102.71 Million USD | 182.122% |
| SI-BONE, Inc. | 5.72 Million USD | -1374.428% |
| TELA Bio, Inc. | -3.94 Million USD | 2236.034% |
| Treace Medical Concepts, Inc. | 57.32 Million USD | -47.157% |
| Vivos Therapeutics, Inc. | 352 Thousand USD | -23863.636% |
| Acutus Medical, Inc. | 12.27 Million USD | -586.961% |
| Talis Biomedical Corporation | -57.06 Million USD | 247.82% |
| Spectral AI, Inc. | -3.5 Million USD | 2509.369% |
| Nano-X Imaging Ltd. | -48.02 Million USD | 275.635% |
| CVRx, Inc. | -59.95 Million USD | 240.69% |
| DIH Holding US, Inc. Warrants | 1.98 Million USD | -4151.302% |
| PetVivo Holdings, Inc. | 1.27 Million USD | -6502.188% |
| Bioventus Inc. | 372.51 Million USD | 77.356% |
| Venus Concept Inc. | 74.3 Million USD | -13.527% |
| TriSalus Life Sciences, Inc. | -10.18 Million USD | 928.442% |
| LivaNova PLC | 62.53 Million USD | -34.894% |
| 908 Devices Inc. | -115.09 Million USD | 173.288% |
| Alphatec Holdings, Inc. | 320.7 Million USD | 73.698% |
| Nemaura Medical Inc. | 9.92 Million USD | -749.893% |
| NeuroPace, Inc. | 54.33 Million USD | -55.239% |
| LENSAR, Inc. | -18.31 Million USD | 560.638% |
| Apyx Medical Corporation | -5.15 Million USD | 1737.585% |
| Cutera, Inc. | 288.3 Million USD | 70.742% |
| STRATA Skin Sciences, Inc. | 7.51 Million USD | -1022.448% |
| BioSig Technologies, Inc. | 262 Thousand USD | -32095.42% |
| Anika Therapeutics, Inc. | -43.83 Million USD | 292.453% |
| ClearPoint Neuro, Inc. | -9.19 Million USD | 1016.969% |
| Integra LifeSciences Holdings Corporation | 1.4 Billion USD | 93.997% |
| Axonics, Inc. | -77.19 Million USD | 209.273% |
| Outset Medical, Inc. | 67.67 Million USD | -24.635% |
| IRIDEX Corporation | -4.28 Million USD | 2067.164% |
| PROCEPT BioRobotics Corporation | -178.01 Million USD | 147.384% |
| IRadimed Corporation | -47.71 Million USD | 276.768% |
| Tivic Health Systems, Inc. | -3.02 Million USD | 2887.574% |
| INVO Bioscience, Inc. | 8.45 Million USD | -898.114% |
| Telesis Bio, Inc. | 32.63 Million USD | -158.471% |
| Viemed Healthcare, Inc. | -2.5 Million USD | 3471.205% |
| Varex Imaging Corporation | 316.9 Million USD | 73.382% |
| Quipt Home Medical Corp. | 81.73 Million USD | -3.202% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | 3132.063% |
| Pulmonx Corporation | -42.36 Million USD | 299.131% |
| Dynatronics Corporation | 6.2 Million USD | -1259.632% |
| Modular Medical, Inc. | -8.04 Million USD | 1148.893% |
| ReShape Lifesciences Inc. | -4.29 Million USD | 2063.044% |
| Semler Scientific, Inc. | -57.13 Million USD | 247.649% |
| InMode Ltd. | -135.39 Million USD | 162.301% |
| Bruker Corporation | 891.3 Million USD | 90.536% |
| Cytosorbents Corporation | 4.18 Million USD | -1917.018% |
| DexCom, Inc. | 2.02 Billion USD | 95.84% |
| Align Technology, Inc. | -840.47 Million USD | 110.036% |
| Viveve Medical, Inc. | -13.81 Million USD | 710.671% |
| ZimVie Inc. | 450.41 Million USD | 81.273% |
| Movano Inc. | -5.86 Million USD | 1537.982% |
| Cytek Biosciences, Inc. | -134.45 Million USD | 162.736% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | 14750.371% |
| DIH Holdings US, Inc. Class A Common Stock | 1.98 Million USD | -4151.302% |
| Tandem Diabetes Care, Inc. | 356.79 Million USD | 76.359% |
| Profound Medical Corp. | -18.17 Million USD | 564.02% |
| Insulet Corporation | 798.1 Million USD | 89.431% |
| enVVeno Medical Corporation | -2.21 Million USD | 3903.066% |
| Surmodics, Inc. | -12.01 Million USD | 802.114% |
| iCAD, Inc. | -21.2 Million USD | 497.718% |
| Nuwellis, Inc. | -2.81 Million USD | 3092.267% |
| Biotricity, Inc. | 23.09 Million USD | -265.275% |
| iRhythm Technologies, Inc. | 93.65 Million USD | 9.929% |
| Aethlon Medical, Inc. | -4.5 Million USD | 1973.797% |
| InspireMD, Inc. | -8.04 Million USD | 1148.502% |
| PAVmed Inc. | 29.08 Million USD | -190.009% |
| BIOLASE, Inc. | 11.34 Million USD | -643.583% |
| Beyond Air, Inc. | 6.22 Million USD | -1254.182% |
| FONAR Corporation | -14.66 Million USD | 675.18% |
| AxoGen, Inc. | 32.26 Million USD | -161.427% |
| Vivani Medical, Inc. | 42 Thousand USD | -200738.095% |
| Tactile Systems Technology, Inc. | -10.65 Million USD | 891.443% |
| Inari Medical, Inc. | -7.16 Million USD | 1277.936% |
| UFP Technologies, Inc. | 40.77 Million USD | -106.877% |
| QT Imaging Holdings, Inc. | 3.06 Million USD | -2648.854% |
| Heart Test Laboratories, Inc. | -4.77 Million USD | 1867.9% |
| Tenon Medical, Inc. | -1.25 Million USD | 6821.275% |
| Autonomix Medical, Inc. Common Stock | -7.6 Million USD | 1209.019% |
| Co-Diagnostics, Inc. | -11.92 Million USD | 807.277% |
| AdaptHealth Corp. | 2.21 Billion USD | 96.196% |
| Sintx Technologies, Inc. | 905 Thousand USD | -9220.663% |
| NanoVibronix, Inc. | -3.27 Million USD | 2673.276% |
| Quanterix Corporation | -132.95 Million USD | 163.443% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | 3132.063% |
| Sensus Healthcare, Inc. | -22.36 Million USD | 477.161% |
| Pacific Biosciences of California, Inc. | 753.71 Million USD | 88.809% |
| TransMedics Group, Inc. | 121.13 Million USD | 30.365% |
| ReWalk Robotics Ltd. | -26.18 Million USD | 422.2% |
| NeuroMetrix, Inc. | -1.49 Million USD | 5757.146% |
| Hyperfine, Inc. | -75.61 Million USD | 211.549% |
| Establishment Labs Holdings Inc. | 152.18 Million USD | 44.574% |
| Biomerica, Inc. | -3.38 Million USD | 2591.935% |
| Bone Biologics Corporation | -3.02 Million USD | 2887.05% |
| AVITA Medical, Inc. | -26.23 Million USD | 421.566% |
| Bluejay Diagnostics, Inc. | -1.83 Million USD | 4688.31% |
| Silk Road Medical, Inc | 64.42 Million USD | -30.935% |